Reuters - Blackstone, Lion Capital to bid for GSK's Lucozade, Ribena

Private equity firms Blackstone and Lion Capital have teamed up to make a formal bid worth more than a billion pounds for Lucozade and Ribena, the two soft drink brands put up for sale by drugmaker GlaxoSmithKline, Sky News reported on Sunday, writes Reuters. Last month, GSK said it had appointed JPMorgan and Greenhill to advise it on the sale.

DealsNorth AmericaUSBriefs